SIGHT SCIENCES, INC. Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
SIGHT SCIENCES, INC. (SGHT) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $972.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2026-08-05
- SIGHT SCIENCES, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2026-06-30 was $91.00K.
- SIGHT SCIENCES, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2026-03-31 was $881.00K.
- SIGHT SCIENCES, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-06-30 was $0.00.
- SIGHT SCIENCES, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-03-31 was $0.00.
- SIGHT SCIENCES, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- SIGHT SCIENCES, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2024 was $124.00K, a 85.39% decline from fiscal 2023.
- SIGHT SCIENCES, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2023 was $849.00K, a 28.64% increase from fiscal 2022.
- SIGHT SCIENCES, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2022 was $660.00K, a 57.06% decline from fiscal 2021.
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | $91.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $972.00K 10-Q · filed 2026-08-05 | ||
| 2026-03-31 | $881.00K 10-Q · filed 2026-05-06 | |||
| 2025-12-31 | $0.00 10-K · filed 2026-03-04 | |||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $0.00 10-Q · filed 2026-08-05 | ||
| 2025-03-31 | $0.00 10-Q · filed 2026-05-06 | |||
| 2024-12-31 | $124.00K 10-K · filed 2026-03-04 | |||
| 2023-12-31 | $849.00K 10-K · filed 2025-03-07 | |||
| 2022-12-31 | $660.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $660.00K derived: sum of 2 quarters · filed 2024-03-13 | $660.00K 10-K · filed 2024-03-13 | |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-10 | $0.00 10-Q · filed 2022-11-10 | ||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $1.51M derived: sum of 2 quarters · filed 2023-03-16 | $1.54M derived: sum of 3 quarters · filed 2023-03-16 | $1.54M 10-K · filed 2023-03-16 |
| 2021-09-30 | $1.51M 10-Q · filed 2022-11-10 | $1.54M derived: sum of 2 quarters · filed 2022-11-10 | $1.54M 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $23.00K 10-Q · filed 2022-08-11 | $23.00K 10-Q · filed 2022-08-11 | ||
| 2020-12-31 | $0.00 10-K · filed 2022-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |